Cell Line : MDA-MB-435S
Cellosaurus Index : CVCL_0622
Cellosaurus ID : MDA-MB-435S
CCLE Name
: MDAMB435S_SKIN
CTRP2 Name
: MDAMB435S
Cancer Type : skin
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| MDA-MB-435S | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | AA-COCF3 | CTRP2 | 0.0081 | 66.0000 |
|
| MDA-MB-435S | abiraterone | CTRP2 | 0.0005 | 17.0000 |
|
| MDA-MB-435S | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-435S | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-435S | Alpelisib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| MDA-MB-435S | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | azacitidine | CTRP2 | 0.0041 | 66.0000 |
|
| MDA-MB-435S | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| MDA-MB-435S | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-435S | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Bortezomib | CTRP2 | 0.0000 | 0.0660 |
|
| MDA-MB-435S | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| MDA-MB-435S | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-435S | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K03911514 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K09344309 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| MDA-MB-435S | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-435S | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| MDA-MB-435S | BRD-K79669418 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| MDA-MB-435S | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-K99584050 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| MDA-MB-435S | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| MDA-MB-435S | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-435S | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | CD-437 | CTRP2 | 0.0011 | 18.0000 |
|
| MDA-MB-435S | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| MDA-MB-435S | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-435S | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| MDA-MB-435S | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-435S | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| MDA-MB-435S | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-435S | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| MDA-MB-435S | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| MDA-MB-435S | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| MDA-MB-435S | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| MDA-MB-435S | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| MDA-MB-435S | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Crizotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MDA-MB-435S | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| MDA-MB-435S | cyanoquinoline 11 | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | Cyclophosphamide | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| MDA-MB-435S | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-435S | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-435S | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-435S | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| MDA-MB-435S | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| MDA-MB-435S | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Erlotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MDA-MB-435S | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-435S | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| MDA-MB-435S | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| MDA-MB-435S | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | FQI-2 | CTRP2 | 0.0020 | 33.0000 |
|
| MDA-MB-435S | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| MDA-MB-435S | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | GMX-1778 | CTRP2 | 0.0000 | 0.2900 |
|
| MDA-MB-435S | gossypol | CTRP2 | 0.0011 | 18.0000 |
|
| MDA-MB-435S | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | GSK461364 | CTRP2 | 0.0081 | 66.0000 |
|
| MDA-MB-435S | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Ibrutinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| MDA-MB-435S | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Irinotecan | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-435S | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | ISOX | CTRP2 | 0.0010 | 17.0000 |
|
| MDA-MB-435S | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MDA-MB-435S | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| MDA-MB-435S | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-435S | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 25.0000 |
|
| MDA-MB-435S | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-435S | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | JW-480 | CTRP2 | 0.0041 | 33.0000 |
|
| MDA-MB-435S | JW-55 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| MDA-MB-435S | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | KU 0060648 | CTRP2 | 0.0160 | 33.0000 |
|
| MDA-MB-435S | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | L-685458 | CTRP2,CCLE | 0.0011 | 37.0000 |
|
| MDA-MB-435S | Lapatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MDA-MB-435S | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-435S | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Linifanib | CTRP2 | 0.0020 | 33.0000 |
|
| MDA-MB-435S | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| MDA-MB-435S | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | MIRA-1 | CTRP2 | 0.0020 | 33.0000 |
|
| MDA-MB-435S | mitomycin | CTRP2 | 0.0015 | 3.1000 |
|
| MDA-MB-435S | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| MDA-MB-435S | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | ML050 | CTRP2 | 0.0020 | 33.0000 |
|
| MDA-MB-435S | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | ML258 | CTRP2 | 0.0020 | 33.0000 |
|
| MDA-MB-435S | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| MDA-MB-435S | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| MDA-MB-435S | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MDA-MB-435S | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| MDA-MB-435S | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Nilotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MDA-MB-435S | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| MDA-MB-435S | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| MDA-MB-435S | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| MDA-MB-435S | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Nutlin-3a | CTRP2,CCLE | 0.0025 | 150.0000 |
|
| MDA-MB-435S | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| MDA-MB-435S | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | ouabain | CTRP2 | 0.0081 | 130.0000 |
|
| MDA-MB-435S | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Paclitaxel | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Palbociclib | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-435S | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Panobinostat | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-435S | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | PD0325901 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-435S | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | PDMP | CTRP2 | 0.0065 | 110.0000 |
|
| MDA-MB-435S | Pevonedistat | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-435S | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-435S | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| MDA-MB-435S | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| MDA-MB-435S | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Piperlongumine | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | PLX-4720 | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| MDA-MB-435S | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| MDA-MB-435S | PRIMA-1MET | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| MDA-MB-435S | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| MDA-MB-435S | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | RAF265 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-435S | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| MDA-MB-435S | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| MDA-MB-435S | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MDA-MB-435S | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| MDA-MB-435S | Selumetinib | CTRP2,CCLE | 0.0025 | 270.0000 |
|
| MDA-MB-435S | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MDA-MB-435S | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MDA-MB-435S | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MDA-MB-435S | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MDA-MB-435S | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MDA-MB-435S | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MDA-MB-435S | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MDA-MB-435S | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| MDA-MB-435S | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MDA-MB-435S | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MDA-MB-435S | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| MDA-MB-435S | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| MDA-MB-435S | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | simvastatin | CTRP2 | 0.0010 | 17.0000 |
|
| MDA-MB-435S | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MDA-MB-435S | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | SN-38 | CTRP2 | 0.0000 | 1.3000 |
|
| MDA-MB-435S | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MDA-MB-435S | Sorafenib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MDA-MB-435S | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | T-5345967 | CTRP2 | 0.0160 | 530.0000 |
|
| MDA-MB-435S | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| MDA-MB-435S | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| MDA-MB-435S | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Tanespimycin | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| MDA-MB-435S | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MDA-MB-435S | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Temsirolimus | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Teniposide | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | tipifarnib-P2 | CTRP2 | 0.0020 | 33.0000 |
|
| MDA-MB-435S | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-435S | Topotecan | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MDA-MB-435S | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| MDA-MB-435S | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| MDA-MB-435S | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| MDA-MB-435S | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | triptolide | CTRP2 | 0.0000 | 0.2900 |
|
| MDA-MB-435S | Tubastatin A | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | UNC0638 | CTRP2 | 0.0010 | 17.0000 |
|
| MDA-MB-435S | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 8.3000 |
|
| MDA-MB-435S | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| MDA-MB-435S | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | Venetoclax | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| MDA-MB-435S | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| MDA-MB-435S | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| MDA-MB-435S | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| MDA-MB-435S | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-435S | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| MDA-MB-435S | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC